Literature DB >> 33732414

Cytokine levels of interleukin-2 and 7 amongst antiretroviral therapy success and failure HIV patients attending the University Teaching Hospital, Yaoundé, Cameroon.

George Mondinde Ikomey1, Cedric Happi Mbakam1, Marie Claire Okomo Assoumou1, Jacobs Graeme Brandon2, Martha Mesembe1, Emilia Lyonga Mbamyah1, Edward Murphy3, Claude Tayou Tagny4.   

Abstract

BACKGROUND: Immune reconstitution complications (IRC) are a major problem faced by HIV treated patients world wide. Interleukin (IL)-2 and IL-7 play vital roles in peripheral T-cell homeostasis. Our study objective was to measure and compare the blood plasma levels of IL-2 and IL-7 amongst antiretroviral therapy (ART) patients attending the Yaoundé University Teaching Hospital, Cameroon.
METHODS: We performed a cross-sectional study with 296 HIV positive patients enrolled between July 2017 and May 2018 at the Yaoundé University Teaching Hospital. IL-2, IL-7, T-cell profile counts and plasma viral load were measured on whole blood specimens. Data obtained were analyzed using Graph Pad Prism 5.0 and Epi info 7.0. Software.
RESULTS: IL-2 and IL-7 plasma concentration levels were higher in patients with ART failure compared to ART success, with a mean SD of 19.4±8 and 17.1±6 pg /ml, 35.26±11 and 21.5±5 pg/ml, with p < 0.001 and < 0.001. There was a direct and significant correlation between viral load, IL-2 and IL-7 with p values = 0.028, and 0.020, respectively. There was an association between IL-2, IL-7 and viral load in relation to the duration on treatment (DT), with p values = 0.003 (R2=0.041, CI= 0.069 - 0.34) ,0.017 (R2=0.027, CI=-0.30 - 0.030), and 0.001 (R2=0.048, CI=-0.047-0.76).
CONCLUSION: Considering that limited surrogate markers are availiable for monitoring immune reconstitution and high associated mortality rates, IL-2 and IL-7 could be a good immunological predictor for ART failure and success in HIV infected individuals.

Entities:  

Keywords:  ART; Homeostasis; Immune reconstitution; Interleukins

Year:  2020        PMID: 33732414      PMCID: PMC7963406          DOI: 10.4314/ijbcs.v14i1.2

Source DB:  PubMed          Journal:  Int J Biol Chem Sci


  22 in total

1.  Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis.

Authors:  Sara Jaleco; Louise Swainson; Valérie Dardalhon; Maryam Burjanadze; Sandrina Kinet; Naomi Taylor
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

Review 2.  The potential role of interleukin-2 in patients with HIV infection.

Authors:  Roger Paredes; Juan Carlos López Benaldo de Quirós; Eduardo Fernández-Cruz; Bonaventura Clotet; H Clifford Lane
Journal:  AIDS Rev       Date:  2002 Jan-Mar       Impact factor: 2.500

3.  Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.

Authors:  Lindi Roberts; Jo-Ann S Passmore; Carolyn Williamson; Francesca Little; Lisa M Bebell; Koleka Mlisana; Wendy A Burgers; Francois van Loggerenberg; Gerhard Walzl; Joel F Djoba Siawaya; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

4.  Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.

Authors:  Nizar Chetoui; Marc Boisvert; Steve Gendron; Fawzi Aoudjit
Journal:  Immunology       Date:  2010-05-04       Impact factor: 7.397

5.  A potential role for interleukin-7 in T-cell homeostasis.

Authors:  T J Fry; E Connick; J Falloon; M M Lederman; D J Liewehr; J Spritzler; S M Steinberg; L V Wood; R Yarchoan; J Zuckerman; A Landay; C L Mackall
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

6.  The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages.

Authors:  Ivan Dzhagalov; Alexis Dunkle; You-Wen He
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival.

Authors:  Wen Qing Li; Qiong Jiang; Annette R Khaled; Jonathan R Keller; Scott K Durum
Journal:  J Biol Chem       Date:  2004-04-30       Impact factor: 5.157

Review 8.  Cytokines and HIV-1: interactions and clinical implications.

Authors:  K Kedzierska; S M Crowe
Journal:  Antivir Chem Chemother       Date:  2001-05

Review 9.  Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.

Authors:  Sébastien Pasquereau; Amit Kumar; Georges Herbein
Journal:  Viruses       Date:  2017-03-30       Impact factor: 5.048

10.  IL-7 and CD4 T Follicular Helper Cells in HIV-1 Infection.

Authors:  Francesca Chiodi; Yonas Bekele; Rebecka Lantto Graham; Aikaterini Nasi
Journal:  Front Immunol       Date:  2017-04-20       Impact factor: 7.561

View more
  1 in total

1.  Differences in Expression of Selected Interleukins in HIV-Infected Subjects Undergoing Antiretroviral Therapy.

Authors:  Beata Szymańska; Karolina Jurkowska; Brygida Knysz; Agnieszka Piwowar
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.